immune checkpoint inhibitors

News

Refining Selection Criteria for Immune Checkpoint Inhibitors in Recurrent Ovarian Cancer

06/19/2020

Tumor mutation burden (TMB), BRCA1/2 mutations, and homologous DNA repair deficiency (HRD) are not associated with immune checkpoint inhibitor response or survival in recurrent ovarian cancer, according to an...

Tumor...

06/19/2020

Journal of Clinical Pathways

Research Reports

Drug Costs vs Probability of Survival in Lung Cancer: Impact of Dosage, Duration, and Immune Checkpoint Inhibitor Combinations

06/18/2019

Helmy M. Guirgis , MD, PhD;

Abstract: Clinical guidelines and pathways recommend use of immune checkpoint inhibitors (ICI) in first- and second-line treatment of advanced/metastatic non-small cell lung cancer (amNSCLC). There is an unmet need...

...

06/18/2019

Journal of Clinical Pathways